Search Results 3001-3010 of 16082 for chemoprevention
Professional development information for the PGY-1 Pharmacy Residency at Mayo Clinic Hospital — Rochester; Minnesota, at Mayo Clinic School of Health ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to evaluate the safety and effieativeness of iloprost on the frequency of and relief from symptomatic digital ischemic episodes in ...
Guojun Bu, Ph.D. “We found if we change this APOE genotype in the peripheral blood, it can affect brain cognition and amyloid-beta pathology. The ε4 genotype ...
The drug used for HIPEC will be carboplatin, a Food and Drug Administration (FDA) approved drug for use in ovarian, fallopian tube or primary peritoneal cancer.
About this study. The purpose of this study is to collect (i) pre-treatment (at the time of breast cancer surgery) normal skin and (ii) on-treatment (around ...
The purpose of this study is to assess the safety and tolerability of ONO-7475 monotherapy in patients with relapsed or refractory acute myeloid leukemia or ...
Pulmonary rehabiltation has been shown to be an effective treatment for patients with chronic obstructive pulmonary disease, however there is currently a ...
Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...
Chemotherapy treatment carries with it a host of potential side effects — fatigue, hair loss and more. Learn about managing chemotherapy side effects. MAYO ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.